Funding for this research was provided by:
National Institute of General Medical Sciences (R15GM100440, GM120712)
National Cancer Institute (CA213185, R15CA213185)
Text and Data Mining valid from 2019-04-11
Received: 7 June 2018
Accepted: 22 March 2019
First Online: 11 April 2019
: L.M.V.T., S.R.F. and W.R.T. are co-inventors of patents (US9862692B2 and US10138216B2) that covers these anticancer agents. The authors declare no other financial or non-financial interests.